Nordic Capital acquires a major shareholding in Nycomed from DLJ Merchant Banking and Blackstone
Press release, March 10, 2005 Nordic Capital Fund V has agreed to acquire a controlling interest in the European pharmaceutical company Nycomed from a group of investors led by DLJ Merchant Banking, part of CSFB’s Alternative Capital Division, and The Blackstone Group. In connection with the transaction, Nycomed is valued at € 1.8 billion.NOT FOR GENERAL RELEASE IN THE UNITED STATES Nycomed provides hospital products throughout the region and general practitioner and pharmacy medicines in selected markets. New products are sourced through licensing agreements in which Nycomed provides late-